Original Research
Accepted on 08 Oct 2024
Roles of NR1I3 and NR1H4 polymorphisms in the susceptibility to antituberculosis druginduced liver injury in China: A case-control study
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 08 Oct 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 11 Sep 2024
in Pharmacogenetics and Pharmacogenomics
Mini Review
Published on 30 Aug 2024
in Pharmacogenetics and Pharmacogenomics
Editorial
Published on 20 Aug 2024
in Pharmacogenetics and Pharmacogenomics
Editorial
Published on 18 Apr 2024
in Pharmacogenetics and Pharmacogenomics
Editorial
Published on 03 Apr 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 05 Jan 2024
in Pharmacogenetics and Pharmacogenomics
Mini Review
Published on 03 Jan 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 13 Dec 2023
in Pharmacogenetics and Pharmacogenomics
Brief Research Report
Published on 28 Nov 2023
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 24 Nov 2023
in Pharmacogenetics and Pharmacogenomics
Editorial
Published on 27 Oct 2023
in Pharmacogenetics and Pharmacogenomics
Original Research
Published on 16 Oct 2023
in Pharmacogenetics and Pharmacogenomics
Brief Research Report
Published on 13 Oct 2023
in Pharmacogenetics and Pharmacogenomics
Mini Review
Published on 18 Sep 2023
in Pharmacogenetics and Pharmacogenomics
Systematic Review
Published on 15 Sep 2023
in Pharmacogenetics and Pharmacogenomics